Existing amenities are not enough to store, and deliver a large volume of vaccines within a short time, say experts. The governments are considering banking on the existing cold chain as a supply chain and logistical issue for storing, transporting, and distributing coronavirus vaccines while some professionals say the main challenge will be to manage such a large volume with the existing capacity. On November 5, 2020, the Bangladesh government signed a trilateral memorandum of understanding (MoU) with the Serum Institute of India and Bangladesh’s Beximco Pharmaceuticals Ltd to get three crore doses of Covid-19 vaccines from Serum, keeping in mind the existing cold chain. In 2020 during the COVID-19 pandemic, vaccines being developed may need ultra-cold storage and transportation temperatures as cold as −70 °C (−94 °F), requiring what has been referred to as a “colder chain” infrastructure. Disruption of a cold chain due to war may produce consequences similar to the smallpox outbreaks in the Philippines during the Spanish–American War. The distributed vaccines were inert due to a lack of temperature control in transport. There are no uniform global practices to follow, customs, legal, and compliance issues, effects on the environment, supplier-related risks, issues with cold chain delivery — packaging, hardware issues, vehicle breakdown, etc. Besides the usual elements of risk that plague normal supply chains, cutting-edge cold chain logistics has its own exclusive set of problems such as product sensitivity, the increasing cost of freight, and growing regulatory hurdles.
Thank you for the auspicious writeup. It in fact
was a amusement account it. Glance advanced to far introduced
agreeable from you! By the way, how can we be in contact?